Von Duprin LLC v. Moran Electric Service, Inc.
20-1793
| 7th Cir. | Sep 3, 2021Background:
- Over decades multiple manufacturers (Von Duprin, Moran, Ertel, Zimmer) released chlorinated solvents (TCE/PCE) at four adjacent Indianapolis properties; contaminants commingled into a groundwater plume and caused vapor intrusion into ~40 homes and a park.
- Von Duprin (successor owner) performed remediation, incurred about $3.2M, then sued adjacent current/former owners under CERCLA §107(a) to recover response costs; Moran and Major counterclaimed under §113(f). Zimmer defaulted.
- At summary judgment the district court held the harm was "theoretically capable of apportionment" and that Major was a BFPP for some properties; it sent apportionment/allocation issues to bench trial.
- After a six‑day bench trial the district court (crediting Moran’s expert Dr. Adam Love) apportioned liability by property (Von Duprin 50%, Major 30% total, Moran 20%), awarded $1.7M recoverable to Von Duprin, and approved future-cost declaratory relief; it denied BFPP for two Major properties.
- On appeal the Seventh Circuit found two reversible errors: (1) the district court improperly resolved the threshold divisibility question at summary judgment without applying the correct substantive and procedural standards; and (2) the court conflated §107(a) apportionment (causation-based) with §113(f) allocation (equitable) and failed to explain its equitable allocation.
Issues:
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Divisibility of §107(a) liability (apportionment) | Von Duprin: harm is indivisible; defendants must prove divisibility | Moran/Major: expert testimony (Dr. Love) gives a reasonable basis to apportion by source chemistry | Reversed district court’s summary‑judgment divisibility finding; vacated and remanded for fuller fact-specific apportionment analysis under Burlington Northern/Restatement §433A standards |
| Post-trial assignment of shares (apportionment vs allocation) | Von Duprin: court improperly conflated apportionment and equitable allocation | Defendants: allocation under §113(f) was appropriate | Vacated allocation judgment; remanded because district court failed to explain how it weighed equitable (Gore) factors and blurred §107/§113 distinctions |
| Major’s BFPP defense for properties | Von Duprin: Major failed the "all appropriate inquiries" timing/attestation requirements | Major: completed Phase I and satisfied AAI | Affirmed in part: Major is BFPP for Moran and Zimmer Packaging; not BFPP for Ertel and Zimmer Paper Facility (failures in timing and required attestations) |
| Recovery under NCP (Von Duprin’s costs) | Von Duprin: costs were incurred in substantial compliance with the NCP | Major: many costs not NCP-consistent | Affirmed: district court did not err; most challenged costs (investigation, vapor mitigation, park remediation, testing) were recoverable as in substantial compliance with the NCP |
| Admissibility of Dr. Adam Love’s expert testimony | Von Duprin: Love’s methodology ignored confounders and should be excluded | Moran: Love is qualified and his methods were admissible | Affirmed: district court did not abuse discretion in admitting Love’s testimony; admissibility ≠ sufficiency to prove divisibility |
Key Cases Cited
- Burlington Northern & Santa Fe Ry. Co. v. United States, 556 U.S. 599 (superseding principles on joint/several vs divisible CERCLA liability)
- United States v. Atlantic Research Corp., 551 U.S. 128 (private §107(a) cost-recovery and distinction from §113(f) contribution)
- Chem-Dyne Corp. v. United States, 572 F. Supp. 802 (S.D. Ohio 1983) (discussion of joint and several liability where harms commingle)
- Env’t Transp. Sys., Inc. v. ENSCO, Inc., 969 F.2d 503 (7th Cir. 1992) (elements of §107(a) cost recovery)
- United States v. NCR Corp., 688 F.3d 833 (7th Cir. 2012) (two-step apportionment inquiry under Burlington Northern)
- NCR Corp. v. George A. Whiting Paper Co., 768 F.3d 682 (7th Cir. 2014) (requirements for explaining equitable allocation under §113(f))
- NutraSweet Co. v. X-L Eng’g Co., 227 F.3d 776 (7th Cir. 2000) (NCP compliance review)
- Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579 (1993) (expert-admissibility/Rule 702 gatekeeping)
- Schultz v. Akzo Nobel Paints, LLC, 721 F.3d 426 (7th Cir. 2013) (standard of review for expert admissibility)
